Legal & General Group Plc Decreases Stock Position in Premier, Inc. (NASDAQ:PINC)

Legal & General Group Plc trimmed its position in Premier, Inc. (NASDAQ:PINC - Free Report) by 12.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 278,524 shares of the company's stock after selling 40,601 shares during the period. Legal & General Group Plc owned about 0.29% of Premier worth $5,905,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Brooklyn Investment Group lifted its stake in shares of Premier by 61,750.0% in the 4th quarter. Brooklyn Investment Group now owns 1,237 shares of the company's stock worth $26,000 after purchasing an additional 1,235 shares during the period. SRS Capital Advisors Inc. increased its holdings in Premier by 157.8% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company's stock valued at $27,000 after buying an additional 786 shares during the last quarter. Keystone Financial Group Inc. purchased a new stake in Premier during the fourth quarter valued at approximately $37,000. Wilmington Savings Fund Society FSB bought a new position in Premier in the third quarter worth approximately $39,000. Finally, Smartleaf Asset Management LLC boosted its stake in shares of Premier by 297.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company's stock worth $40,000 after acquiring an additional 1,427 shares during the last quarter. 74.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Premier news, General Counsel David L. Klatsky sold 10,000 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $19.53, for a total value of $195,300.00. Following the completion of the transaction, the general counsel now directly owns 90,597 shares in the company, valued at $1,769,359.41. This represents a 9.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.96% of the stock is currently owned by company insiders.

Premier Trading Down 0.5 %

Premier stock traded down $0.09 during mid-day trading on Friday, hitting $19.90. The stock had a trading volume of 121,777 shares, compared to its average volume of 1,260,993. Premier, Inc. has a one year low of $17.23 and a one year high of $23.56. The firm has a market capitalization of $1.82 billion, a P/E ratio of -198.78 and a beta of 0.51. The firm's 50 day moving average is $18.83 and its 200 day moving average is $20.41.

Premier Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, June 15th. Stockholders of record on Sunday, June 1st will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.22%. Premier's dividend payout ratio (DPR) is -840.00%.

Analysts Set New Price Targets

Several research firms have recently commented on PINC. Piper Sandler reduced their price objective on Premier from $21.00 to $19.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Robert W. Baird cut their price target on Premier from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Finally, Canaccord Genuity Group decreased their price objective on Premier from $21.00 to $19.00 and set a "hold" rating on the stock in a research note on Wednesday, February 5th. Eight equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.17.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.